158 related articles for article (PubMed ID: 26405767)
1. Volume Rendering of Optical Coherence Tomography Angiography Reveals Extensive Retinal Vascular Contributions to Neovascularization in Ocular Toxoplasmosis.
Spaide RF
Retina; 2015 Nov; 35(11):2421-2. PubMed ID: 26405767
[No Abstract] [Full Text] [Related]
2. Rapid regression of retinal neovascularization following intravitreal bevacizumab in branch retinal vein occlusion imaged by optical coherence tomography angiography.
Brar M; Grewal DS; Sharma M; Grewal SPS
Indian J Ophthalmol; 2018 Apr; 66(4):572. PubMed ID: 29582824
[No Abstract] [Full Text] [Related]
3. Retinal Exudates and Hemorrhages in a Survivor of Breast Cancer.
Moussa K; Kim J; Miller JB
JAMA Ophthalmol; 2019 Feb; 137(2):218-219. PubMed ID: 30489605
[No Abstract] [Full Text] [Related]
4. Optical coherence tomographic angiography of choroidal neovascularization associated with central serous chorioretinopathy.
McClintic SM; Jia Y; Huang D; Bailey ST
JAMA Ophthalmol; 2015 Oct; 133(10):1212-4. PubMed ID: 26135638
[No Abstract] [Full Text] [Related]
5. Treatment of Foveal Neovascularization in a Patient With Type 1 Diabetes.
Jao K; Northey LC; Essex RW
JAMA Ophthalmol; 2018 Sep; 136(9):e182584. PubMed ID: 30242368
[No Abstract] [Full Text] [Related]
6. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF TYPE 3 NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
Kuehlewein L; Dansingani KK; de Carlo TE; Bonini Filho MA; Iafe NA; Lenis TL; Freund KB; Waheed NK; Duker JS; Sadda SR; Sarraf D
Retina; 2015 Nov; 35(11):2229-35. PubMed ID: 26502007
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Therapeutic Challenges.
Peng WY; Zhou SY; Ma J; Gross JG
Retina; 2022 Feb; 42(2):404-409. PubMed ID: 35050931
[No Abstract] [Full Text] [Related]
8. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.
Rishi P; Rishi E; Shroff D
Indian J Ophthalmol; 2009; 57(3):241-2. PubMed ID: 19384026
[No Abstract] [Full Text] [Related]
9. En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation).
Dansingani KK; Naysan J; Freund KB
Eye (Lond); 2015 May; 29(5):703-6. PubMed ID: 25744441
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
[TBL] [Abstract][Full Text] [Related]
11. Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization.
Soliman W; Lund-Andersen H; Larsen M
Acta Ophthalmol Scand; 2006 Oct; 84(5):707-8. PubMed ID: 16965507
[No Abstract] [Full Text] [Related]
12. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
[TBL] [Abstract][Full Text] [Related]
13. Multimodal imaging of early stage 1 type 3 neovascularization with simultaneous eye-tracked spectral-domain optical coherence tomography and high-speed real-time angiography.
Querques G; Souied EH; Freund KB
Retina; 2013 Oct; 33(9):1881-7. PubMed ID: 23644560
[TBL] [Abstract][Full Text] [Related]
14. Transient regression of new vessels after anti-vascular endothelial growth factor monotherapy in proliferative diabetic retinopathy.
Venkatesh R; Anilkumar A; Mangla R; Sharief S; Chhablani J
Clin Exp Optom; 2024 Jul; 107(5):587-588. PubMed ID: 37078163
[No Abstract] [Full Text] [Related]
15. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.
Kuehlewein L; Bansal M; Lenis TL; Iafe NA; Sadda SR; Bonini Filho MA; De Carlo TE; Waheed NK; Duker JS; Sarraf D
Am J Ophthalmol; 2015 Oct; 160(4):739-48.e2. PubMed ID: 26164826
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
Spandau UH; Jonas JB
Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
[No Abstract] [Full Text] [Related]
17. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M
Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2.
Narayanan R; Chhablani J; Sinha M; Dave V; Tyagi M; Pappuru RR; Kuppermann BD
Retina; 2012; 32(10):2001-5. PubMed ID: 22990322
[TBL] [Abstract][Full Text] [Related]
19. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography.
Nagiel A; Sarraf D; Sadda SR; Spaide RF; Jung JJ; Bhavsar KV; Ameri H; Querques G; Freund KB
Retina; 2015 Apr; 35(4):638-47. PubMed ID: 25650713
[TBL] [Abstract][Full Text] [Related]
20. Optical Coherence Tomography Angiography Reveals Mature, Tangled Vascular Networks in Eyes With Neovascular Age-Related Macular Degeneration Showing Resistance to Geographic Atrophy.
Dansingani KK; Freund KB
Ophthalmic Surg Lasers Imaging Retina; 2015 Oct; 46(9):907-12. PubMed ID: 26469229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
